Where Do New Drugs Come From?

In preparing for my “Best of ASH 2014” presentation, I noted there were plenty of new drug presentations, but not as many as were presented at the American Society of Hematology (ASH) annual meeting in 2013.

What Causes Myeloma? New Study Suggests Random Mutations Are Important

A new study published in Science magazine and reported in the New York Times this week shows that random mutations in normal tissues are more important than previously thought. The study, conducted by Johns Hopkins Medicine researchers Cristian Tomasetti and Bert Vogelstein, did not analyze myeloma, but developed principles that apply broadly for all cancers.

Life Tips from a Small Greek Island

In a new book, writer Diane Kochilas explores why “the small Greek island of Ikaria is home to some of the healthiest, most vibrant people on earth.” It’s a phenomeno

Updates from the 2014 Annual Meeting of the American Society Hematology

Another hectic ASH has concluded. My pre-ASH expectations were largely confirmed with the full oral and poster presentations. But some important changes in philosophy and strategies for myeloma management emerged.

The IMF Goes to ASH: Trends, Topics, Progress and Education in Myeloma

To prepare for the upcoming 56th annual meeting of the American Society of Hematology (ASH), which will be held in San Francisco Dec.